Business Context and Reporting Period
This Form 8-K was filed by Integrity Applications, Inc. (not Glucotrack, Inc.) on February 21, 2020, reporting events that occurred on February 14, 2020. The company is incorporated in Delaware and maintains its principal executive offices in Ashdod, Israel.
Key Financial Metrics
The filing details a specific capital raise event rather than periodic financial performance metrics.
- Capital Raised: $15,000,000 aggregate gross purchase price.
- Shares Issued: 37,500,000 shares of common stock.
- Price Per Share: $0.40 (calculated from aggregate price and share count).
- Revenue, Profit, Cash Flow, Debt: The filing text does not provide a clear value for these operational metrics.
Material Changes
The primary material change is the entry into a definitive material agreement and the unregistered sale of securities. The company completed a private placement with an accredited investor, resulting in a significant increase in outstanding common stock and cash inflow on the closing date of February 14, 2020.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal covenants. However, the agreement includes a covenant requiring the Company to file a resale registration statement within 90 days of closing, which must become effective within 120 days of filing. The shares were issued as restricted securities under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
Investor Verification Checklist
- Verify the identity of the accredited investor purchasing the 37.5 million shares.
- Confirm the filing and effectiveness status of the required resale registration statement within the 90/120-day window.
- Review the updated capitalization table to assess dilution impact on existing shareholders.
- Check subsequent filings for the use of the $15 million proceeds.